These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 18193423

  • 1. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS, Jobe DA, Asp KE, Callister SM, Mathiason MA, Meyer LA, Bottner WA, Cole CE, Farnen JP, Frisby KA.
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [Abstract] [Full Text] [Related]

  • 2. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L, Andrýs C, Krejsek J, Belada DZ, Zák P, Siroký O, Malý J.
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [Abstract] [Full Text] [Related]

  • 3. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 4. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A, Ribatti D, Digiesi G.
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [Abstract] [Full Text] [Related]

  • 5. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J, Blonski JZ, Robak T.
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [Abstract] [Full Text] [Related]

  • 6. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.
    Rigolin GM, Maffei R, Rizzotto L, Ciccone M, Sofritti O, Daghia G, Cibien F, Cavazzini F, Marasca R, Cuneo A.
    Cancer; 2010 Apr 15; 116(8):1926-37. PubMed ID: 20166207
    [Abstract] [Full Text] [Related]

  • 7. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G.
    Haematologica; 1999 May 15; 84(5):419-24. PubMed ID: 10329920
    [Abstract] [Full Text] [Related]

  • 8. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY.
    Eur Heart J; 2004 Mar 15; 25(5):371-6. PubMed ID: 15033248
    [Abstract] [Full Text] [Related]

  • 9. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
    Brunner M, Thurnher D, Heiduschka G, Grasl MCh, Brostjan C, Erovic BM.
    J Surg Oncol; 2008 Dec 01; 98(7):545-50. PubMed ID: 18792958
    [Abstract] [Full Text] [Related]

  • 10. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortelezzi A.
    Arthritis Rheum; 2004 Apr 01; 50(4):1296-304. PubMed ID: 15077314
    [Abstract] [Full Text] [Related]

  • 11. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P.
    Nephrol Dial Transplant; 2009 May 01; 24(5):1495-9. PubMed ID: 19039027
    [Abstract] [Full Text] [Related]

  • 12. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct 01; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 13. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
    Wierzbowska A, Robak T, Krawczyńska A, Pluta A, Wrzesień-Kuś A, Cebula B, Robak E, Smolewski P.
    Ann Hematol; 2008 Feb 01; 87(2):97-106. PubMed ID: 17849117
    [Abstract] [Full Text] [Related]

  • 14. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
    Molica S, Cutrona G, Vitelli G, Mirabelli R, Molica M, Digiesi G, Ribatti D, Ferrarini M, Vacca A.
    Leuk Res; 2007 Nov 01; 31(11):1575-8. PubMed ID: 17485110
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
    Smolej L, Andrys C, Peková S, Schwarz J, Belada D, Zák P.
    Haematologica; 2006 Oct 01; 91(10):1432-3. PubMed ID: 17018398
    [Abstract] [Full Text] [Related]

  • 16. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T, Porteous A, Nicolle A, Proctor SJ, Anderson JJ, Summerfield G.
    Int J Oncol; 2008 Jul 01; 33(1):169-74. PubMed ID: 18575763
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep 01; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D, Phay C, Brown W, Gray-Statchuk L, Furlong P, Lock M, Chin-Yee I, Keeney M, Allan AL.
    Cytometry B Clin Cytom; 2009 Mar 01; 76(2):107-17. PubMed ID: 18727054
    [Abstract] [Full Text] [Related]

  • 19. Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.
    Molica S, Digiesi G, Mauro F, Mirabelli R, Cutrona G, Vitelli G, Morabito F, Iuliano F, Foà R, Ferrarini M.
    Leuk Res; 2009 Jan 01; 33(1):162-5. PubMed ID: 18556064
    [Abstract] [Full Text] [Related]

  • 20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J.
    Cytometry B Clin Cytom; 2007 Sep 01; 72(5):363-70. PubMed ID: 17428002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.